NA
Natco Pharma
NATCOPHARM.NS·NSEHyderabad INFounded 19814,000 employees
Mid CappharmaPublicOncology
Platform: Generic Onc
Market Cap
$2B
All Drugs
2
Clinical Trials
2
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (NATCOPHARM.NS)
Loading NATCOPHARM.NS stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| NAT-2164 | NAT-2164 | Phase 1/2 | 1 | RET | Gastric CaCTCL | ||
| Talazumab | NAT-5390 | Phase 2/3 | 1 | B7-H3 | EpilepsyLGS |
SEC Filings & Financial Documents
SEC filings are not available for NSE-listed companies.
Natco Pharma trades on NSE (IN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (2)